Crispr Therapeutics shares owned by Capital Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Advisors
from 13F filings
Historical chart of Capital Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $333k | 5.1k | 64.81 |
| 2025-06-30 | $340k | 7.0k | 48.64 |
| 2025-03-31 | $11M | 308k | 34.03 |
| 2024-12-31 | $12M | 310k | 39.36 |
| 2024-09-30 | $14M | 301k | 46.98 |
| 2024-06-30 | $15M | 278k | 54.01 |
| 2024-03-31 | $18M | 264k | 68.16 |
| 2023-12-31 | $16M | 255k | 62.60 |
| 2023-09-30 | $11M | 232k | 45.39 |
| 2023-06-30 | $12M | 216k | 56.14 |
| 2023-03-31 | $7.5M | 166k | 45.23 |
| 2022-12-31 | $5.3M | 130k | 40.65 |
| 2022-09-30 | $6.9M | 128k | 54.07 |
| 2022-06-30 | $7.7M | 126k | 60.77 |
| 2022-03-31 | $6.6M | 105k | 62.77 |
| 2021-12-31 | $7.8M | 103k | 75.78 |
| 2021-09-30 | $7.9M | 71k | 111.93 |
| 2021-06-30 | $11M | 70k | 161.89 |
| 2021-03-31 | $8.3M | 68k | 121.85 |
| 2020-12-31 | $13M | 88k | 153.11 |
| 2020-09-30 | $12M | 137k | 83.64 |
| 2020-06-30 | $13M | 137k | 92.94 |
| 2020-03-31 | $5.7M | 134k | 42.41 |
| 2019-12-31 | $7.7M | 127k | 60.91 |
| 2019-09-30 | $5.5M | 116k | 47.10 |
| 2019-06-30 | $5.5M | 116k | 47.10 |
| 2019-03-31 | $1.9M | 53k | 35.73 |
| 2018-12-31 | $3.4M | 118k | 28.57 |
| 2018-09-30 | $4.8M | 107k | 44.35 |
| 2018-06-30 | $6.3M | 106k | 58.76 |
| 2018-03-31 | $6.8M | 149k | 45.71 |
| 2017-12-31 | $3.5M | 150k | 23.48 |